Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
about
Improving the clinical impact of biomaterials in cancer immunotherapy.Immune modulation of the tumor microenvironment for enhancing cancer immunotherapyStimulating antitumor immunity with nanoparticlesSynthetic Nanoparticles for Vaccines and ImmunotherapyNanotechnology-Based Drug Delivery Systems for Melanoma Antitumoral Therapy: A ReviewCombination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cellsTargeting cancer cells in the tumor microenvironment: opportunities and challenges in combinatorial nanomedicine.Towards programming immune tolerance through geometric manipulation of phosphatidylserine.Cuprous oxide nanoparticle-inhibited melanoma progress by targeting melanoma stem cells.Poly(styrene)-b-poly(DL-lactide) copolymer-based nanoparticles for anticancer drug delivery.The era of bioengineering: how will this affect the next generation of cancer immunotherapy?Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells.Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer.Increased antitumor effects using IL-2 with anti-TGF-β reveals competition between mouse NK and CD8 T cells.Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.Hydrogels and scaffolds for immunomodulationInjectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy.Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies.Biophysical characterization of small molecule antiviral-loaded nanolipogels for HIV-1 chemoprophylaxis and topical mucosal application.Development of individualized anti-metastasis strategies by engineering nanomedicinesSynthesis of Nanogels via Cell Membrane-Templated Polymerization.Nanoparticle-Based Manipulation of Antigen-Presenting Cells for Cancer Immunotherapy.Biomaterial Strategies for Immunomodulation.Nanogel-based delivery of mycophenolic acid ameliorates systemic lupus erythematosus in mice.Active drug encapsulation and release kinetics from hydrogel-in-liposome nanoparticlesCuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondriaHollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.Lymphatic vessels and tertiary lymphoid organs.Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles.Overendocytosis of superparamagnetic iron oxide particles increases apoptosis and triggers autophagic cell death in human osteosarcoma cell under a spinning magnetic fieldLipid-enveloped hybrid nanoparticles for drug delivery.Melanoma immunotherapy: historical precedents, recent successes and future prospects.Immunotherapy for the management of advanced melanoma: the next steps.Using functional nanomaterials to target and regulate the tumor microenvironment: diagnostic and therapeutic applications.Insights into the Transforming Growth Factor-β Signaling Pathway in Cutaneous Melanoma.Merging the best of both worlds: hybrid lipid-enveloped matrix nanocomposites in drug delivery.Specific protein markers for stem cell cross-talk with neighboring cells in the environment.Manipulating the intersection of angiogenesis and inflammationLipid-coated polymeric nanoparticles for cancer drug delivery.Nanotechnology for protein delivery: Overview and perspectives.
P2860
Q26766267-006B6963-0F8A-4BE6-BC61-E0AF6958933EQ27002646-C2E2CDB4-CD9E-4A79-A7B4-96DD15D7D460Q27027780-811617FE-C9E0-4F5C-8E79-168C65A38205Q28085375-5111D761-83DF-40D6-B744-CF01FA32EA9EQ28394719-1D127633-9488-4342-B5D9-C7C5E55A3574Q28834339-CAD226CC-7135-4265-A734-9DC5C11B297CQ30279055-83981173-7479-4AF7-B3EE-9D28495C5D50Q30751004-63BD3530-B27E-4865-9923-BFFC9F3E2333Q33553465-259F2A78-5396-4175-B04F-2011C5F09816Q33734382-62F8C31F-D63F-457B-950A-5B690B31BA2CQ33815087-624A8790-FEC0-4E29-A20D-FEB9573BB26BQ34428078-0431385A-FB54-4CB2-945A-6638087A74BEQ34479313-8696A1EE-1FB6-47F3-9D5D-BA8F9D322089Q34563034-59B49119-0ED0-4818-A43F-0455488DCC8CQ34675068-F850C6DB-88A3-4301-9A4B-5F75B31C02DFQ34725541-01BF81EF-9BFF-4F66-88FC-3CB6BF7E4DD2Q35053924-6AF7C0E1-0009-48D2-A218-3EC5A4F36EF8Q35684362-A7BC000B-EBAC-488B-AB2F-6B98D6FAE3EDQ35947035-01FAEEFF-5A7F-4B7C-B230-DE4BA2CFEE2BQ35967474-6BB5A9AE-D50A-4EBA-B70C-926B8CC67779Q36037531-80F363D8-503B-4DDB-AA6A-39D9DEBC22B2Q36269694-EFF4B85C-420C-459C-965C-6D71F8CA3CCBQ36703124-417FFDFC-1D69-4FE2-8FAD-65E325E94C92Q36733468-9C51F36E-FC45-483F-BF96-F3F1AFA1BB37Q37029578-FB38FB76-C212-4EC3-92F6-D01D2CF3362FQ37148313-C7926F23-554C-4D35-AFAD-4E1DBD8A8341Q37582113-8789840A-1B02-4F0B-9C36-786018D65A57Q37602241-7EB07F46-6224-41F1-BCEB-0273C96FD7EDQ37625459-A5513F99-9167-4EC9-B1F0-176E5EBEAC8FQ37705979-312CA3E4-C89D-428E-A8AB-12DAA6C23A6AQ38071910-30068A21-9F5C-45FC-995C-51660D385D50Q38081911-C5942DB5-E7C5-4C72-8585-F961DBCD35D0Q38091675-91FF4442-D1D0-47FA-ADB1-DA8B9053EDFEQ38109107-08B789EA-96B2-4FCE-94C0-5E8E9CD47254Q38110273-44F7603C-071C-4760-8A23-554DEA4C03C8Q38150118-63E78194-283A-45BD-874A-289D39217DB8Q38175402-F274E543-13D2-4153-BC1E-3C2255160A2BQ38260351-E606DC04-24D6-46C6-B294-19ED4FBE5798Q38556750-EAB4B64B-8D63-411C-BCDC-4E51647C8764Q38605185-1337AE2E-4E0A-4798-BCC0-F0C7B3312BD8
P2860
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Combination delivery of TGF-β ...... enhances tumour immunotherapy
@ast
Combination delivery of TGF-β ...... enhances tumour immunotherapy
@en
type
label
Combination delivery of TGF-β ...... enhances tumour immunotherapy
@ast
Combination delivery of TGF-β ...... enhances tumour immunotherapy
@en
prefLabel
Combination delivery of TGF-β ...... enhances tumour immunotherapy
@ast
Combination delivery of TGF-β ...... enhances tumour immunotherapy
@en
P2093
P2860
P356
P1433
P1476
Combination delivery of TGF-β ...... enhances tumour immunotherapy
@en
P2093
Ann Habermann
Anthony F Ferrandino
David Gonzalez
Eric Stern
Jason Criscione
Jason Park
Michael Look
Paula Licona Limon
Ragy Ragheb
Richard A Flavell
P2860
P2888
P304
P356
10.1038/NMAT3355
P407
P577
2012-07-15T00:00:00Z